The Vivo group is now attempting to block the special dividend payments to you via lawsuits and by sending threatening letters and messages to the Company’s stock transfer agent and board members.

In an in vivo Galleria mellonella burn wound model, a 5 mg/kg topical dose provides better protection than Opis16a against Enterobacter cloacae NICD 16103. These findings highlight the potential of ...

"Bold letters just said, ‘Hey! You got the scholarship.’ I was, like, ‘Oh, wow! That’s cool!’ I was really surprised I got that one," Kecoughtan High School senior Malakye Brown said ...

Business Wire IndiaSinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that its board of... "Kalkine Media dolor ...